Advisory: Dated alert on Avingtrans withdrawn
An alert on Avingtrans AVG.L receiving 510(k) clearance from the U.S. Food and Drug Administration for its orthopaedic 3D imaging product, Adaptix Ortho350 has been withdrawn as it was dated. For the alert on Adaptix from Nov. 10, click nTUCWLTG STORY_NUMBER:nFWN3X20NN STORY_DATE:26/11/2025 STORY_TIME:[01:41:30 PM GMT] ((bangalore.newsroom@thomsonreuters.com))